Known for its freezing winters, Finland is warming up to global entrepreuners and investors to boost its life science ...

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

As BIOSPAIN 2026 comes to end, delve into what as been at the center of this edition's discussion: what comes after we have ...

Delve into the strategy of Viatris, a company that built its reputation around generics and is steadily moving beyond to find ...

Brain biomarkers were long hard to pin down. See how new Parkinson's and Alzheimer's biomarkers are changing that.

September is often a strong month for the biopharma sector as the industry returns from the summer lull, keen on forging biotech deals.

Merck’s new BioReliance® Facility in Darmstadt, Germany, will support biologics testing, GMP release testing and stability ...

The companies ADARx Pharmaceuticals, Electra Therapeutics, and Enveda bagged the biggest biotech funding rounds overall in ...

Look into Spain's biotech, an ecosystem that has matured and transforms promissing science into ventures but faces challenges ...

Discover biotech and big pharma’s emerging interest in developing macrocyclic drugs for cardiometabolic diseases.

AB Science AbbVie Abcam Abingworth Abivax Ablynx AC Immune Actelion Acticor Biotech Adaptimmune ADC Therapeutics Adocia Affibody Affimed Agendia AiCuris Allergan ...